|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
JPS62501537A
(ja)
*
|
1984-12-21 |
1987-06-25 |
テクニクロン・リサ−チ・パ−トナ−ズ・ワン |
リンパ球細胞を電気的に不滅化するための方法
|
|
DE3531430A1
(de)
|
1985-09-03 |
1987-03-05 |
Biotest Pharma Gmbh |
Verfahren zur gewinnung von komponenten aus einer fluessigkeit mit in raeumlich getrennten bereichen vorliegenden komponenten
|
|
US4963489A
(en)
*
|
1987-04-14 |
1990-10-16 |
Marrow-Tech, Inc. |
Three-dimensional cell and tissue culture system
|
|
US4900322A
(en)
|
1986-09-22 |
1990-02-13 |
Adams James D |
Blood component pooling valve and kit
|
|
US5476996A
(en)
*
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5399493A
(en)
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
|
US5747641A
(en)
|
1989-12-21 |
1998-05-05 |
Biogen Inc |
Tat-derived transport polypeptide conjugates
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5849288A
(en)
*
|
1990-01-15 |
1998-12-15 |
Yeda Research And Development Co. Ltd. |
Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
US6753162B1
(en)
|
1991-03-07 |
2004-06-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
NZ241855A
(en)
|
1991-03-07 |
1994-04-27 |
Gen Hospital Corp |
Use of therapeutic cells to obtain cellular response to infection, tumours or autoimmune-generated cells, cells with chimaeric receptors (with binding component and destruction signal), dna encoding the receptor, vectors and antibodies to receptor
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
AU781922B2
(en)
|
1991-12-17 |
2005-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5289858A
(en)
|
1991-12-18 |
1994-03-01 |
Abbott Laboratories |
System for accommodating withdrawal of liquid from a bulk supply
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
EP0903408A3
(en)
|
1992-08-21 |
2005-11-02 |
Biogen, Inc. |
Tat-derived transport polypeptide
|
|
US5580760A
(en)
|
1993-02-22 |
1996-12-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
FUSE binding protein and cDNA therefor
|
|
WO1995003402A1
(en)
*
|
1993-07-22 |
1995-02-02 |
Merck & Co., Inc. |
EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL
|
|
US5599705A
(en)
*
|
1993-11-16 |
1997-02-04 |
Cameron; Robert B. |
In vitro method for producing differentiated universally compatible mature human blood cells
|
|
CA2184356A1
(en)
|
1994-03-03 |
1995-09-08 |
Russell P. Rother |
Terminal complement inhibitor fusion genes and proteins
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
US6713247B1
(en)
|
1996-09-03 |
2004-03-30 |
Signal Pharmaceuticials, Inc. |
Human CNS cell lines and methods of use therefor
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
EP0893493A3
(de)
*
|
1997-07-21 |
2002-12-04 |
Aventis Pharma Deutschland GmbH |
Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
|
|
GB9720585D0
(en)
|
1997-09-26 |
1997-11-26 |
Smithkline Beecham Biolog |
Vaccine
|
|
JP2002505077A
(ja)
|
1997-12-10 |
2002-02-19 |
ワシントン大学 |
抗病原体システムおよびその使用方法
|
|
EP1070757B1
(en)
|
1998-04-08 |
2005-02-02 |
Shionogi & Co., Ltd. |
Methods for isolating osteoclast precursor cells and inducing the differentiation of the same into osteoclasts
|
|
US6835567B1
(en)
|
1998-04-14 |
2004-12-28 |
Signal Pharmaceuticals, Inc. |
PNS cell lines and methods of use therefor
|
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
|
US6913925B1
(en)
|
1998-08-12 |
2005-07-05 |
Signal Pharmaceuticals Llc |
Human mesencephalon cell lines and methods of use therefor
|
|
WO2000062067A1
(en)
|
1999-02-28 |
2000-10-19 |
Washington University |
Novel transduction molecules and methods for using same
|
|
AU4070500A
(en)
*
|
1999-04-05 |
2000-10-23 |
Biocrystal Limited |
Assay kits and methods for immune complex-mediated activation involving shed antigens
|
|
US6358739B1
(en)
|
1999-04-12 |
2002-03-19 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells
|
|
DE60031260T2
(de)
*
|
1999-04-12 |
2007-05-03 |
Heart Biosystems Gmbh |
Vorübergehend-immortalisierte zellen zur verwendung in gentherapie
|
|
US6451601B1
(en)
*
|
1999-04-12 |
2002-09-17 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells for use in gene therapy
|
|
US7135287B1
(en)
*
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
|
US7311920B1
(en)
*
|
1999-10-08 |
2007-12-25 |
University Of Maryland Biotechnology Institute |
Virus coat protein/receptor chimeras and methods of use
|
|
DK1228233T3
(da)
*
|
1999-11-10 |
2007-05-14 |
Rigel Pharmaceuticals Inc |
Fremgangsmåder og sammensætninger omfattende grönfluorescerende proteiner (GFP) fra Renilla
|
|
EP1103615A1
(en)
*
|
1999-11-25 |
2001-05-30 |
Universite De Geneve |
Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
|
|
US20010049393A1
(en)
*
|
1999-12-07 |
2001-12-06 |
Whitehead Institute For Biomedical Research |
Methods for defining MYC target genes and uses thereof
|
|
EP1285577A4
(en)
*
|
2000-05-15 |
2007-05-09 |
Sonoko Habu |
CHIMERIC MOUSE HAVING IMMUNITY CREATED BY USE OF HUMAN CD34 POSITIVE CELLS AND USE THEREOF
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
US20030072794A1
(en)
*
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US20070248618A1
(en)
*
|
2004-03-16 |
2007-10-25 |
Cohen David I |
Tat-Based vaccine Compositions and Methods of Making and Using Same
|
|
ATE428790T1
(de)
|
2000-09-25 |
2009-05-15 |
Genetronics Inc |
Verbessertes system zur regulation der transgenexpression
|
|
AU2002227112A1
(en)
|
2000-10-30 |
2002-05-15 |
Kalobios, Inc. |
Affinity maturation by competitive selection
|
|
EP1379535B1
(en)
|
2000-11-01 |
2012-06-13 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Expression vectors able to elicit improved immune response and methods of using same
|
|
US7145055B2
(en)
*
|
2000-12-01 |
2006-12-05 |
Central Institute For Experimental Animals |
Method of producing a mouse suitable for the engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
|
|
WO2002057436A2
(en)
|
2001-01-19 |
2002-07-25 |
Gendel Limited |
Red blood cell from a transgenic animal as vehicle for polypeptide delivery
|
|
JP3454818B1
(ja)
*
|
2001-03-16 |
2003-10-06 |
直哉 小林 |
肝臓細胞の増殖方法、該方法により得られる肝臓細胞、およびその用途
|
|
WO2002097050A2
(en)
*
|
2001-05-31 |
2002-12-05 |
Novartis Ag |
Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
|
|
DE60203125T2
(de)
|
2001-08-31 |
2006-04-06 |
Avidex Ltd., Abingdon |
Löslicher t zell rezeptor
|
|
CN1408850A
(zh)
*
|
2001-09-18 |
2003-04-09 |
王虹 |
人血树突状细胞永生化技术
|
|
CN100506978C
(zh)
|
2001-09-21 |
2009-07-01 |
中国人民解放军军事医学科学院野战输血研究所 |
一种新的造血干/祖细胞的富集方法及其体外定向诱导分化
|
|
GB0124391D0
(en)
|
2001-10-11 |
2001-11-28 |
Gene Expression Technologies L |
Control of gene expression
|
|
CA2466138A1
(en)
|
2001-11-02 |
2003-05-15 |
Shen Wu Wang |
B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
|
|
EP1321034A1
(en)
*
|
2001-12-21 |
2003-06-25 |
Pfizer Products Inc. |
Disruption of the phosphodieterase 10 gene
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
US7670781B2
(en)
|
2002-01-03 |
2010-03-02 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal
|
|
AU2003216288B2
(en)
|
2002-02-13 |
2009-09-24 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
CN1240439C
(zh)
|
2002-03-28 |
2006-02-08 |
南京凯基生物科技发展有限公司 |
肿瘤基因开关药物
|
|
US7211191B2
(en)
|
2004-09-30 |
2007-05-01 |
Thermogenesis Corp. |
Blood component separation method and apparatus
|
|
AU2003228517B2
(en)
|
2002-04-16 |
2007-06-21 |
Dana-Farber Cancer Institute, Inc. |
Cancer models
|
|
GB2387599B
(en)
|
2002-04-17 |
2005-08-10 |
Jason Peter Brown |
Methods for producing antibodies
|
|
CA2485363C
(en)
|
2002-05-10 |
2014-10-28 |
New Century Pharmaceuticals, Inc. |
Ferritin fusion proteins for use in vaccines and other applications
|
|
EP1652857B9
(en)
*
|
2002-05-16 |
2009-10-14 |
Bavarian Nordic A/S |
Fusion protein of HIV regulatory/accessory proteins
|
|
DK1531666T3
(da)
*
|
2002-05-29 |
2014-01-13 |
Regeneron Pharma |
Inducerbart eukaryot-ekspressionssystem
|
|
ES2602145T3
(es)
|
2002-09-06 |
2017-02-17 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inmunoterapia con linfocitos específicos de antígeno seleccionados in vitro después de quimioterapia supresora de linfocitos no mieloablativa
|
|
WO2004033685A1
(en)
|
2002-10-09 |
2004-04-22 |
Avidex Ltd |
Single chain recombinant t cell receptors
|
|
PT1408114E
(pt)
*
|
2002-10-11 |
2007-04-30 |
Imvision Gmbh |
Moléculas modulares de transportes de antigénios ( moléculas mat ) para modulação de respostas imunitárias, correspondentes construções, processos e utilizações.
|
|
WO2004035535A2
(en)
|
2002-10-15 |
2004-04-29 |
Yeda Research And Development Co. Ltd. |
Erythrocyte differentiation factor, gene encoding same, and methods of use thereof
|
|
NZ570811A
(en)
|
2002-11-09 |
2009-11-27 |
Immunocore Ltd |
T cell receptor display
|
|
EP1570061A2
(en)
|
2002-12-05 |
2005-09-07 |
Imperial College Innovations Limited |
Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
WO2004084805A2
(en)
|
2003-03-19 |
2004-10-07 |
The J. David Gladstone Institutes |
Acetylated tat polypeptides and methods of use thereof
|
|
EP1623017B1
(en)
|
2003-05-08 |
2010-09-15 |
Life Technologies Corporation |
Generation and isolation of antigen-specific t cells
|
|
WO2005014785A2
(en)
|
2003-06-18 |
2005-02-17 |
The George Washington University |
Conditionally-immortalized hematopoietic progenitor cell lines
|
|
WO2005084158A2
(en)
*
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
|
IL161903A0
(en)
|
2003-07-17 |
2005-11-20 |
Gamida Cell Ltd |
Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
|
|
US7705049B2
(en)
*
|
2004-01-21 |
2010-04-27 |
New York University |
Methods for treating non-melanoma cancers with PABA
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
CA2567349C
(en)
|
2004-05-19 |
2012-11-27 |
Avidex Ltd |
Method of improving t cell receptors
|
|
WO2005113595A2
(en)
|
2004-05-19 |
2005-12-01 |
Avidex Ltd |
High affinity ny-eso t cell receptor
|
|
DE602005022595D1
(de)
|
2004-06-29 |
2010-09-09 |
Immunocore Ltd |
Einen modifizierten t-zellen-rezeptor exprimierende zellen
|
|
US20060068469A1
(en)
|
2004-08-17 |
2006-03-30 |
Research Development Foundation |
Bacterial vector systems
|
|
GB0420963D0
(en)
|
2004-09-21 |
2004-10-20 |
Reneuron Ltd |
Hepatocyte
|
|
US7767453B2
(en)
*
|
2004-10-20 |
2010-08-03 |
Whitehead Institute For Biomedical Research |
Cultured hematopoietic stem cells and method for expansion and analysis thereof
|
|
WO2007067183A1
(en)
|
2005-12-09 |
2007-06-14 |
The Regents Of The University Of California |
Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
|
|
US20060156422A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Medical Research Council |
Methods and compositions for the generation of antibodies
|
|
JP2008535823A
(ja)
|
2005-03-25 |
2008-09-04 |
キュラジェン コーポレイション |
テネイシンの主要な抗原に対する抗体
|
|
CA2609342A1
(en)
|
2005-04-26 |
2006-11-02 |
Andrei L. Gartel |
Nucleoside compounds and methods of use thereof
|
|
WO2006125962A2
(en)
|
2005-05-25 |
2006-11-30 |
Medigene Limited |
T cell receptors which specifically bind to vygfvracl-hla-a24
|
|
US20070054843A1
(en)
*
|
2005-08-26 |
2007-03-08 |
Yeomans David C |
Methods for treatment of headaches by administration of oxytocin
|
|
US20070047583A1
(en)
|
2005-08-29 |
2007-03-01 |
Siemens Aktiengesellschaft |
Method for using a short address in a packet header
|
|
JP2009511081A
(ja)
|
2005-10-18 |
2009-03-19 |
ナショナル ジューイッシュ メディカル アンド リサーチ センター |
条件的に不死化された長期幹細胞およびそのような細胞を作製および使用する方法
|
|
AU2006311725B2
(en)
*
|
2005-11-04 |
2011-11-24 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of NAV1.8 gene
|
|
EP1792627A1
(en)
|
2005-12-05 |
2007-06-06 |
ImVisioN AG |
Modulation of the immune response by administration of intralymphatic transduction allergen (ITAG-)-molecules
|
|
US8088379B2
(en)
|
2006-09-26 |
2012-01-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Modified T cell receptors and related materials and methods
|
|
EP2087000A2
(en)
|
2006-09-29 |
2009-08-12 |
Immunocore Ltd. |
T cell therapies
|
|
EP2134852A4
(en)
*
|
2007-03-13 |
2010-04-28 |
Nat Jewish Health |
PROCESS FOR THE PRODUCTION OF ANTIBODIES
|
|
US20110218210A1
(en)
|
2007-11-02 |
2011-09-08 |
Taiga Biotechnologies |
Compounds for treating abnormal cellular proliferation
|
|
US9534205B2
(en)
|
2008-03-17 |
2017-01-03 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
|
AU2009246876B2
(en)
|
2008-05-16 |
2015-04-02 |
Htyr Acquisition Llc |
Antibodies and processes for preparing the same
|
|
US8481492B2
(en)
|
2008-06-13 |
2013-07-09 |
Life & Brain Gmbh |
Fusion protein and use thereof
|
|
EP2746387A1
(en)
|
2008-07-21 |
2014-06-25 |
Taiga Biotechnologies, Inc. |
Differentiated anucleated cells and method for preparing the same
|
|
CA2735522C
(en)
*
|
2008-08-28 |
2017-04-18 |
Taiga Biotechnologies, Inc. |
Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
|
|
US9107909B2
(en)
|
2008-11-06 |
2015-08-18 |
Indiana University Research & Technology Corp. |
Materials and methods to enhance hematopoietic stem cells engraftment procedures
|
|
ES2394180T3
(es)
|
2008-11-24 |
2013-01-23 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh |
Receptor de células T de alta afinidad y uso del mismo
|
|
WO2011100477A2
(en)
|
2010-02-10 |
2011-08-18 |
Taiga Biotechnologies, Inc. |
Antibodies and processes for preparing the same
|
|
US20120107317A1
(en)
|
2010-10-27 |
2012-05-03 |
The University Of Hong Kong |
Use of cytoplasmic c-myc for regulating immune responses
|
|
US20120244133A1
(en)
|
2011-03-22 |
2012-09-27 |
The United States of America, as represented by the Secretary, Department of Health and |
Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
|
|
SI2755997T1
(sl)
|
2011-09-15 |
2018-11-30 |
The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health |
T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage
|
|
CN107557334B
(zh)
|
2012-05-03 |
2021-06-25 |
弗雷德哈钦森癌症研究中心 |
增强亲和力的t细胞受体及其制备方法
|
|
DE102012209673A1
(de)
|
2012-06-08 |
2013-12-24 |
Artcline Gmbh |
Verfahren zum Herstellen einer Leukozytenpräparation und Leukozytenpräparation
|
|
SG10201700459XA
(en)
|
2012-07-20 |
2017-02-27 |
Taiga Biotechnologies Inc |
Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
|
|
EP2877489A4
(en)
|
2012-07-27 |
2016-04-13 |
Univ Illinois |
MANIPULATION OF T-CELL RECEPTORS
|
|
US20140109246A1
(en)
|
2012-09-24 |
2014-04-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods of generating xenochimaeric mice with tumor and hematopoietic system from the same heterologous species
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
CA2902423C
(en)
|
2013-03-01 |
2021-06-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing enriched populations of tumor-reactive t cells from tumor
|
|
CN111643524B
(zh)
|
2013-03-01 |
2023-09-05 |
美国卫生和人力服务部 |
从外周血中产生肿瘤反应性t细胞富集群的方法
|
|
US9365825B2
(en)
|
2013-03-11 |
2016-06-14 |
Taiga Biotechnologies, Inc. |
Expansion of adult stem cells in vitro
|
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
|
CN106459918A
(zh)
|
2014-04-24 |
2017-02-22 |
得克萨斯州大学系统董事会 |
施加诱导多能干细胞产生过继细胞疗法产品
|
|
KR102582035B1
(ko)
|
2014-12-24 |
2023-09-22 |
넥스이뮨, 인크. |
면역요법을 위한 나노입자 조성물 및 방법
|
|
TWI756199B
(zh)
|
2016-01-15 |
2022-03-01 |
美商伯克利之光生命科技公司 |
製造患者專ㄧ性抗癌治療劑之方法及使用該治療劑之治療方法
|
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|